Clinical Trials for Cutaneous Melanoma

Find clinical trials for cutaneous melanoma. Discover research opportunities and treatment options in your area.

30 Active Trials Found

Showing 30 trials on this page

Page 1 of 2

A Phase II, Randomised Clinical Trial of Nivolumab and Ipilimumab Combined With Relatlimab for Patients With Resectable Advanced Melanoma Identified as Poor Responders to Immunotherapy Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

NCT ID: NCT06999980

This clinical trial, called the Neo IRENIE trial, is exploring a new combination of immunotherapy treatments for patients with advanced melanoma that can be surgically removed. Specifically, it foc...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Wollstonecraft, New South Wales, Australia

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

NCT ID: NCT07068074

This clinical trial is studying whether elderly patients (75 years or older) with early skin melanoma can be safely and effectively treated by just removing the melanoma with surgery, without doing...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Pittsburgh, Pennsylvania, United States

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT ID: NCT05544929

This clinical trial is exploring the safety and effectiveness of a new treatment called KFA115, both on its own and in combination with another medication called pembrolizumab, for patients with ce...

Clinical Trials for Cutaneous Melanoma

30 Active Trials Found

A Phase II, Randomised Clinical Trial of Nivolumab and Ipilimumab Combined With Relatlimab for Patients With Resectable Advanced Melanoma Identified as Poor Responders to Immunotherapy Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)

A Beta-only IL-2 ImmunoTherapY Study

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Observational Basket Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

ACTengine® IMA203 Combined With mRNA-4203

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies

Study of RP1 Monotherapy and RP1 in Combination With Nivolumab

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Related Conditions